Inhibrx Biosciences
INBX----
Inhibrx Biosciences (INBX)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening cond...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Inhibrx Biosciences Analyst Rating
View MoreForecast & Rating
Jun 2, 2026Price forecast
$277.50228.85%
Forecast & RatingBuy
3analysts
- Strong buy66.67%
- Buy0.00%
- Hold33.33%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 16 at 08:04 AM
Inhibrx Biosciences expands Oxford Finance loan facility to USD 500 million
- rttnews · Jun 24 at 09:09 AM
6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & More
- rttnews · Jun 15 at 08:35 AM
Inhibrx Biosciences's BLA Filing For Ozekibart Gets FDA Acceptance
- Top Gainers&Losers · May 22 at 05:00 PM
Top 10 US Stock Losers (5.22)
- Tip Ranks · May 15 at 07:45 AM
Stifel Nicolaus Sticks to Their Buy Rating for Inhibrx Biosciences Inc (INBX)
- StockTitan · May 14 at 07:02 AM
Inhibrx Reports First Quarter 2026 Financial Results | INBX Stock News
